Article Details

AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab ...

Retrieved on: 2022-07-01 14:41:42

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca Shares Data at EASL and ESMO World GI for IMFINZI® (durvalumab .... View article details on HISWAI: https://www.galvnews.com/news_ap/business/article_a028571b-b95b-5ccd-8075-c502f63e5a4d.html

Excerpt

Cristian Massacesi, Chief Medical Officer and Oncology Chief Development Officer, AstraZeneca, said: “The HIMALAYA results show a consistent survival ...

Article found on: www.galvnews.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up